Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Robert E. Ettlinger"'
Publikováno v:
Journal of Musculoskeletal Pain. 12:69-74
Objective: Recognition of autonomic dysregulation in fibromyalgia [FMS] suggests new treatment options such as dopamine 3 specific agonists already used for Parkinson's disease and restless leg syndrome [RLS].Methods: For 22 patients with the America
Autor:
Jacques Caldwell, Theodore W. Rooney, Gary R. Botstein, Daniel E. Furst, Fredrick Dietz, Bruce A. Baethge, George E. Mclaughlin, David E. Yocum, Anthony Sebba, Michael H. Weisman, Larry W. Moreland, Robert E. Ettlinger, W. Neal Roberts, Harvey E. Golden, Herbert B. Lindsley, Kathryn E. Welch, Bruce M. Rothschild, Marshall Sack
Publikováno v:
Arthritis & Rheumatism. 42:357-365
Objective To investigate the usefulness of hydroxychloroquine (HCQ) dose-loading to increase the percentage of responders or rate of response in treating rheumatoid arthritis (RA). Methods Two hundred twelve patients with early RA (mean duration 1.5
Autor:
Somayaji Ramamurthy, Rene Cailliet, Glen D. Solomon, Robert C. Schenk, Robert E. Ettlinger, I. Jon Russell, Haworth Continuing Features Submission
Publikováno v:
Journal of Musculoskeletal Pain. 1:153-160
Autor:
Robert E. Ettlinger, Andrew J. Holman, Richard A. Neiman, Paul B. Brown, Moni Blazej Neradilek, David D. Dryland
Publikováno v:
Current pain and headache reports. 14(6)
Perspectives of patients with fibromyalgia influence their likelihood of participating in randomized placebo-controlled trials and potentially clash with current, well-established methodology of randomized controlled trial design. Mandates to use onl
Autor:
Elizabeth A. Tindall, Consuelo M. Blosch, Larry W. Moreland, Michael Schiff, Roy Fleischmann, William J. Koopman, Scott Baumgartner, Kendall Mohler, Arthur L. Weaver, Robert E. Ettlinger, Michael B. Widmer, Stanley Cohen
Publikováno v:
The New England journal of medicine. 337(3)
Tumor necrosis factor (TNF) is a proinflammatory cytokine involved in the pathogenesis of rheumatoid arthritis, and antagonism of TNF may reduce the activity of the disease. This study evaluated the safety and efficacy of a novel TNF antagonist - a r
Publikováno v:
Arthritis & Rheumatism. 22:820-825
The clinical and pathologic findings of 2 infants and 7 older children with polyarteritis nodosa who were autopsied are reported. The most frequent clinical features included prolonged high fever, skin rash, abdominal symptoms, leukocytosis, proteinu